Foresters Investment Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$10.2M Sell
95,300
-400
-0.4% -$41.1K 0.2% 171
2019
Q2
$9.74M Sell
95,700
-300
-0.3% -$28.8K 0.17% 195
2019
Q1
$8.63M Sell
96,000
-10,100
-10% -$875K 0.15% 220
2018
Q4
$8.84M Buy
106,100
+41,300
+64% +$3.87M 0.17% 187
2018
Q3
$6.99M Buy
64,800
+3,200
+5% +$351K 0.11% 251
2018
Q2
$6.77M Buy
61,600
+3,200
+5% +$333K 0.12% 250
2018
Q1
$5.86M Sell
58,400
-21,100
-27% -$2.16M 0.1% 237
2017
Q4
$7.83M Sell
79,500
-837
-1% -$79.3K 0.12% 209
2017
Q3
$7.52M Buy
80,337
+100
+0.1% +$10.6K 0.12% 199
2017
Q2
$8.92M Buy
80,237
+1,137
+1% +$120K 0.15% 187
2017
Q1
$7.77M Buy
79,100
+100
+0.1% +$9.53K 0.14% 194
2016
Q4
$7.3M Buy
79,000
+200
+0.3% +$17.2K 0.13% 194
2016
Q3
$6.67M Buy
78,800
+200
+0.3% +$16.8K 0.12% 193
2016
Q2
$6.4M Buy
78,600
+3,600
+5% +$274K 0.12% 191
2016
Q1
$5.36M Hold
75,000
0.11% 200
2015
Q4
$5.34M Buy
+75,000
New +$5.04M 0.11% 193

Other funds holding DGX

Foresters Investment Management's DGX Position: Q3 2019 in Review

Foresters Investment Management reduced its Quest Diagnostics (DGX) stake by 0.42% in Q3 2019, selling an estimated $41.1K and leaving 95,300 shares worth $10.2M. The position accounts for 0.2% of the portfolio, ranked #171.

Foresters Investment Management first reported a position in DGX in Q4 2015 and has held it in 16 quarters since. 676 funds tracked by Wall St. Rank hold DGX as of Q3 2019.

  • Foresters Investment Management held 95,300 shares of Quest Diagnostics worth $10.2M as of Q3 2019.
  • Foresters Investment Management sold 400 Quest Diagnostics shares in Q3 2019, an estimated $41.1K.
  • Quest Diagnostics made up 0.2% of Foresters Investment Management's portfolio in Q3 2019, its #171 holding.
  • Foresters Investment Management first reported a position in Quest Diagnostics in Q4 2015 and has held it in 16 quarters since.
  • 676 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2019.

Based on Foresters Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.